It revealed that, together with average tumor size, presence of symptoms, and expression of EPAS1, 2-fold increase in the expression of TMEM72 and TMEM116 decreased the odds of metastases significantly for 22 % and 40 %, respectively (Table 2A). Here, EPAS1 is linked to neoplasm.